Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
This study is testing a nurse-led, app-based program called "virtual diabetes care" for adults with Type 2 Diabetes who are on Medicaid and use insulin. This program uses MyChart messaging for education, phone calls with nurses to help solve problems, and the mySugr app to track your blood sugar and help adjust your treatment. The goal is to see if this program can improve how well you manage your diabetes, specifically by looking at your A1C (a measure of average blood sugar over 2-3 months) and how often your blood sugar is in a healthy range. You might be able to join if you are 18 to 90 years old, have Type 2 Diabetes, use insulin, have Medicaid, and own a smartphone. The study aims to enroll 60 participants, but its current recruitment status is unclear.
- Study design
- This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 60 participants.
- What's involved
- You would participate in a 12-month program involving app-based education, phone calls with nurses, and remote monitoring through the mySugr app. Your A1C and blood glucose levels will be measured at baseline, 3, 6, 9, and 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will be followed for 12 months after starting the program.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Helen NC Chen, PhD · PRINCIPAL_INVESTIGATOR · Rutgers School of Nursing
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Glycemic control: glycated hemoglobin AICbaseline, 3, 6, 9, and 12 months
Electronic health record extracted lab test drawn at baseline, 3, 6, 9, and 12 months
- Glycemic control - the rate of pre-prandial blood glucose readings in target rangebaseline, 3, 6, 9, and 12 months
Home monitoring glucometer at baseline and diabetes app report containing blood glucose readings at home for 3, 6, 9, and 12 months. It is calculated from the number of BG that met the target divided by the total number of BG tested.
- Glycemic control - the rate of peak postprandial blood glucose reading in target rangebaseline, 3, 6, 9, and 12 months
Blood glucose reading obtained from patient's home monitoring glucometer at baseline and diabetes app report containing blood glucose readings at home for 3, 6, 9, and 12 months. It is calculated from the number of BG that met the target divided by the total number of BG tested.